Literature DB >> 15830238

Functional outcome and life quality after endoprosthetic reconstruction following malignant tumours around the knee.

G Skaliczki1, I Antal, J Kiss, K Szalay, J Skaliczki, M Szendroi.   

Abstract

Between 1993 and 2002, we treated 43 patients with malignant musculoskeletal tumours of the knee region. All patients had partial resection of the femur or tibia together with endoprosthetic replacement. We were able to follow-up 23 patients with an average follow-up of 30 (12-97) months. Complications occurred in ten cases, of which one was a case of local recurrence. Most of the patients were completely satisfied with their condition, with a decreased walking distance as the only notable restriction. There was no correlation between the functional outcome and life quality assessment and the type of the implanted prosthesis, length of resected bone and type of resection. However, patients with tumours in the distal femur had significantly better functional and life quality outcome than those with a proximal tibial tumour.

Entities:  

Mesh:

Year:  2005        PMID: 15830238      PMCID: PMC3456875          DOI: 10.1007/s00264-005-0655-5

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  15 in total

1.  Function after amputation, arthrodesis, or arthroplasty for tumors about the knee.

Authors:  I E Harris; A R Leff; S Gitelis; M A Simon
Journal:  J Bone Joint Surg Am       Date:  1990-12       Impact factor: 5.284

2.  Prosthetic replacement of the distal femur for primary bone tumours.

Authors:  P Roberts; D Chan; R J Grimer; R S Sneath; J T Scales
Journal:  J Bone Joint Surg Br       Date:  1991-09

3.  Prosthetic arthroplasty of the knee after resection of a sarcoma in the proximal end of the tibia. A report of sixteen cases.

Authors:  S M Horowitz; J M Lane; J C Otis; J H Healey
Journal:  J Bone Joint Surg Am       Date:  1991-02       Impact factor: 5.284

4.  Etiology and results of tumor endoprosthesis revision surgery in 64 patients.

Authors:  P Z Wirganowicz; J J Eckardt; F J Dorey; F R Eilber; J M Kabo
Journal:  Clin Orthop Relat Res       Date:  1999-01       Impact factor: 4.176

5.  Questionnaire on the perceptions of patients about total knee replacement.

Authors:  J Dawson; R Fitzpatrick; D Murray; A Carr
Journal:  J Bone Joint Surg Br       Date:  1998-01

6.  One-stage revision surgery for infected megaprostheses.

Authors:  G Holzer; R Windhager; R Kotz
Journal:  J Bone Joint Surg Br       Date:  1997-01

7.  Kotz modular femur and tibia replacement. 28 tumor cases followed for 3 (1-8) years.

Authors:  H J Zwart; A H Taminiau; J W Schimmel; J R van Horn
Journal:  Acta Orthop Scand       Date:  1994-06

8.  Limb salvage surgery in bone tumour with modular endoprosthesis.

Authors:  B K Sanjay; P G Moreau
Journal:  Int Orthop       Date:  1999       Impact factor: 3.075

9.  Limb-sparing surgery for high-grade malignant tumors of the proximal tibia. Surgical technique and a method of extensor mechanism reconstruction.

Authors:  M M Malawer; K A McHale
Journal:  Clin Orthop Relat Res       Date:  1989-02       Impact factor: 4.176

10.  The use of bone allografts for limb salvage in high-grade extremity osteosarcoma.

Authors:  M C Gebhardt; D I Flugstad; D S Springfield; H J Mankin
Journal:  Clin Orthop Relat Res       Date:  1991-09       Impact factor: 4.176

View more
  2 in total

1.  Short-stem reconstruction for megaendoprostheses in case of an ultrashort proximal femur.

Authors:  Ralf Dieckmann; Marcel-Philipp Henrichs; Georg Gosheger; Steffen Höll; Jendrik Hardes; Arne Streitbürger
Journal:  BMC Musculoskelet Disord       Date:  2014-05-31       Impact factor: 2.362

Review 2.  Unravelling the heterogeneity of soft tissue and bone sarcoma patients' health-related quality of life: a systematic literature review with focus on tumour location.

Authors:  Dide den Hollander; Winette T A Van der Graaf; Marco Fiore; Bernd Kasper; Susanne Singer; Ingrid M E Desar; Olga Husson
Journal:  ESMO Open       Date:  2020-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.